Drug intelligence / Profile preview

Classic Induction

Development stage
Phase 4
Lead developer
University of Texas Health Science Center at Houston
Modality
Small Molecules
Administration
Intravenous
01

Overview

Classic Induction (CI) is a standardized pharmacological regimen used for the induction of general anesthesia and facilitation of endotracheal intubation. As defined in clinical studies by The University of Texas Health Science Center, Houston, the protocol involves the sequential intravenous administration of lidocaine (1 mg/kg), an opioid such as fentanyl (1-2 mcg/kg), a sedative-hypnotic agent like propofol (1-2 mg/kg), and a non-depolarizing neuromuscular blocking agent, specifically rocuronium (0.6 mg/kg). This combination is designed to provide analgesia, loss of consciousness, and muscle relaxation to ensure optimal conditions for tracheal intubation while maintaining hemodynamic stability. The regimen serves as a control arm in trials evaluating alternative induction techniques like Modified Time Principle Induction (MTPI).

Other names
Classical Induction
02

Targets

GABRR (GABA-A receptor subunit rho)MOR (Mu opioid receptor)Muscle-type nicotinic acetylcholine receptorSCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)GABRA1 (Gamma-aminobutyric acid type A receptor alpha 1 subunit)

Beyond the preview

Go deeper on Classic Induction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Classic Induction.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call